The abnormal expression of LOXL1-AS1 is closely related to the clinical characteristics of patients, such as tumor size, stage, metastasis and prognosis, indicating that LOXL1-AS1 as a new type of cancer biomarker has great clinical value. The gene discussed is LOXL1; the disease is cancer.